Companies


 
CytuVax has developed an intelligent vaccination platform technology for the treatment of cancer. The vaccination technology consists of a powerful adjuvant composed of depot-bound cytokines acting as immune response modifiers. This allows full control of the specificity, direction and strength of the resulting immune response against the selected tumor.

www.cytuvax.com